Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2004

29 Dec 2004
Change of Directors’ Interest Notices
23 Dec 2004
Successful Completion of Share Purchase Plan
7 Dec 2004
Positive Test Results for Anti-HIV Compound
2 Dec 2004
Issue of Key Virion Patent
24 Nov 2004
Biotron Share Purchase Plan
22 Nov 2004
Biotron Share Purchase Plan
10 Nov 2004
SARS Virus Treatment Target Identified
28 Oct 2004
Successful Virion Project Toxicity Testing
22 Oct 2004
Quarterly Report 30 September 2004
15 Oct 2004
Presentation to Annual General Meeting
15 Oct 2004
Resolutions passed at Annual General Meeting
6 Oct 2004
Notice of change of interests of substantial holder
16 Sep 2004
Notice of Annual General Meeting
30 Aug 2004
Preliminary Final Report for year ended 30 June 2004
30 Jul 2004
Share Price Fluctuation Query
15 Jul 2004
Quarterly Report 30 June 2004
30 Jun 2004
Annual report for the year ended 30 June 2004
23 Jun 2004
Virion Project Toxicity Results
26 May 2004
Operations Update
29 Apr 2004
Quarterly report 31 March 2004
27 Feb 2004
Half-year report 31 December 2003
6 Feb 2004
Shareholder update
14 Jan 2004
$1.7 million Start grant for Clinical Development of HIV/AIDS Drugs

<<
2024

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 6 September 2024 Legal Notices and Privacy